360 ONE funds disclose 7.28% holding after unlisted-to-listed share conversion on IPO
Paras Healthcare has disclosed a SAST update received from 360 ONE funds.
By ScoutQuest · · 2 min read
- 360 ONE schemes holding
- 78,81,992 shares, or 7.28%
- Shares acquired in this disclosure
- Nil
- Mode of acquisition
- unlisted shares conversion into listed shares on account of an IPO; date of acquisition October 28, 2026 (listing date)
What the update reports
Paras Healthcare has disclosed a Regulation 29(1) SAST update it received from 360 ONE funds, named as the acquirer along with persons acting in concert. Seven schemes are listed:
- 360 ONE Special Opportunities Fund – Series 9, Series 10, Series 11, Series 12 and Series 13
- 360 ONE Private Equity Fund – Series 2
- 360 ONE Equity Opportunity Fund – Series 4
The numbers in the disclosure
- Holding before the acquisition under consideration: 78,81,992 shares, being 7.28% of total share/voting capital and 7.28% of total diluted share/voting capital.
- Shares carrying voting rights acquired: Nil.
- Holding after the acquisition: 78,81,992 shares, 7.28% of total share/voting capital and 7.28% of total diluted share/voting capital.
- Total voting capital before and after the acquisition: ~10.82 crore shares.
- Total diluted share/voting capital after the acquisition: ~10.85 crore shares.
Why the disclosure was triggered
The stated mode of acquisition is "Unlisted shares conversion into listed shares on account of an IPO", and the date of acquisition is given as October 28, 2026 (listing date). In simple terms, the funds were already shareholders while the shares were unlisted; the listing turned those unlisted shares into listed shares, and that event is what has been reported. The details of acquisition row shows Nil shares acquired, so this does not reflect fresh buying of shares in the market.
Who the holders are
The form states that the acquirer does not belong to the promoter/promoter group. This places the holding as that of financial investors rather than a promoter holding.
How a retail investor can read it
- The disclosure is about a pre-existing block of shares becoming listed, not about a new purchase.
- The percentage holding is the same before and after: 7.28%.
- The share counts indicate the company's total voting capital is ~10.82 crore shares, with a diluted figure of ~10.85 crore shares.
- The identity of the holders and the size of the holding are the factual takeaways; the update itself does not set out any view on the company's operations or prospects.
In short
A large financial-investor holding has been formally reported to the exchanges following the share listing, with the share count and percentage unchanged across the event and no fresh shares acquired in this disclosure.
Also from Paras Healthcare
Paras Healthcare Ltd: shareholder reports a transaction via conversion and public issue
30 Oct 2026
Board authorises four Key Managerial Personnel to determine materiality and make disclosures
28 Oct 2026
Board approves Code of Practices and Procedures for Fair Disclosure of UPSI
28 Oct 2026
More numbers
- Shares held by 360 ONE funds before acquisition78,81,992
- Holding as % of total share/voting capital7.28%
- Shares held by 360 ONE funds after acquisition78,81,992
- Total voting capital before acquisition10,82,01,194 Shares
- Total voting capital after acquisition10,82,01,194 Shares
- Total diluted share/voting capital after acquisition10,85,00,790 Shares
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.